TREOS BIO
Treos Bio, Inc. is a computational immunology and immunotherapy company which has developed a proprietary technology to predict in silico likely responders to cancer immunotherapies and to design in silico next generation targeted immunotherapies for a large population of cancer patients.
TREOS BIO
Industry:
Biotechnology Clinical Trials Health Care Health Diagnostics Therapeutics
Founded:
2013-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.treosbio.com
Total Employee:
11+
Status:
Active
Contact:
+44-20-3141 7370
Total Funding:
24.42 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Apple Mobile Web Clips Icon Google Font API WordPress Google Analytics LetsEncrypt SSL By Default Font Awesome
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
ASC Oncology
ASC Oncology offers reverse clinical engineering to support patients and physicians.
Elstar Therapeutics
Fulfilling the promise of precision cancer immunotherapy through a powerful new approach to generating multi-functional therapeutics.
GammaDelta Therapeutics
GammaDelta Therapeutics is developing the potential of gamma delta (γδ) cells
Médipole Garonne
Médipole Garonne Clinic, focused on orthopedic surgery and care of the athlete, has reached its phase of maturity.
OmiCure
OmiCure helps clinicians choose therapy and diet for cancer patients.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Current Employees Featured
Gábor Illés CFO @ Treos Bio
CFO
Christopher C. Gallen Chairman and CEO @ Treos Bio
Chairman and CEO
Enikő Tőke CSO @ Treos Bio
CSO
John Hautman CLO @ Treos Bio
CLO
Levente Molnár HEAD OF BIOINFORMATICS @ Treos Bio
HEAD OF BIOINFORMATICS
Founder
Investors List
The Future Fund
The Future Fund investment in Convertible Note - Treos Bio
Luminous Ventures
Luminous Ventures investment in Convertible Note - Treos Bio
BXR Partners LLP
BXR Partners LLP investment in Venture Round - Treos Bio
Official Site Inspections
http://www.treosbio.com
- Host name: 198.49.23.145
- IP address: 198.49.23.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Treos Bio"
About Us — Treos Bio
The second area of his research includes the organization of Hungarian activities in clinical trials for gastrointestinal oncology, he has been and/or currently is the principal investigator in 132 …See details»
Treos Bio
Treos Bio is a clinical stage company developing next generation of effective off-the-shelf peptide cancer vaccines based on a novel perspective on how HLA genes influence immune …See details»
Treos Bio - Crunchbase Company Profile & Funding
Contact Email info@treosbio.com Phone Number +44-20-3141 7370 Treos Bio, Inc. is a computational immunology and immunotherapy company which has …See details»
Treos Bio 2025 Company Profile: Valuation, Funding & Investors
Treos Bio General Information Description. Operator of a clinical-stage biotechnology company intended to change the paradigm of cancer immunotherapy development. The company uses …See details»
TREOS BIO - LinkedIn
Treos Bio is a clinical stage company introducing a disruptive computational technology to change the paradigm of cancer immunotherapy development by resolving the dual challenges of …See details»
Treos Bio - 2025 Company Profile - Tracxn
Mar 5, 2025 Treos Bio - Developer of cancer vaccines and companion diagnostics. Raised a total funding of $22M over 2 rounds from 45 investors. Valued at $45.2M. Founded by John …See details»
Products — Treos Bio
Personalized Peptide Cancer Vaccines PEPI Panel – A unique approach to off-the-shelf personalized peptide immunotherapy design. Our Peptide Library (PEPI Panel) currently …See details»
Treos Bio Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Jul 1, 2023 For more information, visit www.treosbio.com Media Contact:Daniel LevineLevine Media Group+1 (510) 280-5405danny@levinemediagroup.com ... The statistics for drugs in …See details»
Treos Bio - Overview, News & Similar companies | ZoomInfo.com
Popular Searches TREOS BIO Ltd Treos Bio Inc Treos Bio Corp Treos Bio Treosbio SIC Code 87,873 NAICS Code 54,541 Show more. Treos Bio Org Chart. Phone Email. Christopher …See details»
Treos Bio Ltd. (Treos Bio Ltd.) - 药物管线_专利_临床试验_投融营 …
The Company is also developing off-the-shelf immunotherapies personalized to an individual patient’s HLA genotype for several types of solid tumors. Treos has raised $45 million to date. …See details»
Treos Bio - VentureRadar
At TREOS we use our cancer vaccine technology to develop precision cancer immunotherapies. These therapies are peptide vaccines that induce potent... ... Find out ...See details»
Treos Bio - Craft
Treos Bio is a company that uses its cancer vaccine technology to develop precision cancer immunotherapy. These therapies are peptide vaccines that induce potent immune responses …See details»
Treos Bio Company Information - Funding, Investors, and More
Track over 71,000 companies. Discover Fast-growing Global startups. Seedtable uses technology and people to track over 71,000 companies to help you find the right ones to partner with.See details»
Treos Bio | SPRIM Global Investments
New York. 545 West 25th Street, 20th Floor New York, NY, USA 10001See details»
Treos Bio to Present New Colorectal Cancer Immunotherapy Data …
Jun 28, 2024 LONDON and BOSTON, May 08, 2024 – Treos Bio, a clinical-stage biotechnology firm leveraging data science and proprietary biomarkers to create precision peptide …See details»
Treos Bio Announces First Patient Dosed in Phase 2 Trial of ...
LONDON, June 27, 2022 (GLOBE NEWSWIRE) -- Treos Bio Limited (“Treos”), a clinical stage biotechnology company using data science and proprietary biomarkers to develop precision …See details»
Treos Bio Enters into Clinical Collaboration to Evaluate its ...
Jul 7, 2021 Company expects to initiate a Phase I/II trial in Q4 2021 LONDON, July 07, 2021 (GLOBE NEWSWIRE) -- Treos Bio Limited (“Treos”), a clinical stage biotechnology company …See details»
Treos Bio Enters into Clinical Collaboration to Evaluate
Jul 7, 2021 More information can be found at www.treosbio.com. Media Contact: Solebury Trout Zara Lockshin +1-646-378-2960 zlockshin@soleburytrout.com ...See details»
Science — Treos Bio
TREOS proposes that PEPIs could serve as key targets for the design of effective immunotherapies, as they help the immune system to efficiently recognize cancer cells …See details»
New Meta-Analysis Shows Treos Bio’s Promiscuous Epitopes in …
LONDON, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Treos Bio announced the results of a meta-analysis from three clinical trials evaluating its investigational off-the-shelf immunotherapy, …See details»